NCT05833815
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
- Locations
-
- Banaras Hindu University Varanasi, Uttar Pradesh, India
Clinical trial condition
Gallbladder Neoplasms
Explore clinical trials studying Gallbladder Neoplasms. Study availability and eligibility vary by location and protocol.
208 public trials
35 recruiting studies
Gallbladder Neoplasms trial results
NCT02920554
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
- Locations
-
- the Catholic University of Korea St. Vincent's Hospital Suwon, South Korea
NCT03637569
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +16 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT05757336
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Recruiting
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
NCT05184400
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
- Locations
-
- Herlev & Gentofte Hospital Herlev, Copenhagen, Denmark
Enrolling by Invitation
Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer
NCT07310069
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
- Locations
-
- Xinhua hospital Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)
NCT06963060
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
NCT06901622
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, China
Enrolling by Invitation
Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction
NCT06671418
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Cholangiocarcinoma Non-resectable, +9 more
- Locations
-
- Erasmus MC Rotterdam, Netherlands
Not Yet Recruiting
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
NCT07623642
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China